Ovarian Cancer and Mutation 5382insC in BRCA1 Gene (Clinical Case)
Abstract
Keywords
Full Text:
PDFReferences
Gonzalez-Angulo AM, Timms KM, Liu S, Chen H, Litton JK, Potter J, et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer. Clin Cancer Res. 2011; 17: 1082–1089.
Broek AJ, Schmidt MK, Veer LJ,[et al.] Worse Breast Cancer Prognosis of BRCA1/BRCA2 Mutation Carriers: What's the Evidence? A Systematic Review with Meta-Analysis. PLOS. 2015. DOI: 10.1371/journal.pone.0120189
Rumiantseva UV, Ruminatsev PO, Kiseleva MV. Characteristics of treatment and prophylaxis of hereditary forms of breast and ovarian cancer. Clinical and genetic screening in carriers of BRCA 1/2 mutations and persons with high oncologic risk. Voprosy oncologii. 2008; 54 (3): 251-9.
Pilynska MA, Dybsky SS, Dybska OB, Pedan LR. Detection of chromosome instability in descendants of parents irradiated as a result of Chornobyl disaster. Tsytolohiia i henetyka. 2005; 39 (4): 32-40.
Tkachenko MM, Liubarets TF. Genetic consequences of remote stochastic effects of ionized irradiation. Fiziol. zhurnal. 2012; 58 (5): 78-85.
Refbacks
- There are currently no refbacks.
Copyright (c) 2015 O. V. Paliychuk, Z. I. Rossokha

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.